Login
$CYH
$2.66 -$0.18 (6.34%) Live

$CYH 3 SEC Filings

Filed On Filing
14 May 2026 Form 3: Rice David V., EVP-Clinical Operations & CMO

No securities owned

05 Jan 2026 Form 3: Posey Phillip A., SVP & CAO

Holds 27,924 shares of Common Stock

02 Jan 2025 Form 3: Benet Miguel S, President and CMO

Holds 78,875 shares of Common Stock

07 May 2024 Form 3: Lopez Fawn D, Director

Holds 0 shares of Common Stock

02 Oct 2023 Form 3: Cova Charles J, Regional President

Holds 33,701 shares of Common Stock

13 Sep 2023 Form 3: Burgess Ronald L Jr, Director

Holds 0 shares of Common Stock

11 May 2022 Form 3: Brooks Susan W, Director

Holds 0 shares of Common Stock

01 Mar 2022 Form 3: Pitt Justin D, EVP and General Counsel

Holds 97,019 shares of Common Stock

17 Sep 2021 Form 3: Hastings Joseph Arthur, Director

Holds 10,792 shares of Common Stock

20 May 2021 Form 3: Stockton Kevin A, Regional President

Holds 49,984 shares of Common Stock

20 May 2021 Form 3: Nicely David E, Regional President

Holds 64,686 shares of Common Stock

20 May 2021 Form 3: Medley Mark B, Regional President

Holds 39,808 shares of Common Stock

20 May 2021 Form 3: Mason Austen D, Regional President

Holds 17,000 shares of Common Stock

20 May 2021 Form 3: Campbell Chad A, Regional President

Holds 43,916 shares of Common Stock

02 Jan 2020 Form 3: Johnson Jason K, SVP & CAO

Holds 39,460 shares of Common Stock

12 Dec 2018 Form 3: Hirsch Elizabeth T, Director

No securities owned

23 Feb 2018 Form 3: Ramsey Beryl, Division President

Holds 14,823 shares of Common Stock

13 Dec 2017 Form 3: Krishnan K Ranga, Director

Holds 0 shares of Common Stock

13 Dec 2017 Form 3: Dinkins Michael, Director

Holds 0 shares of Common Stock

17 May 2017 Form 3: Aaron Thomas J, EVP and CFO

Holds 213,549 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support